AIP
XERS icon

Ameritas Investment Partners’s Xeris Biopharma Holdings XERS Stock Holding History

Ameritas Investment Partners’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$74.4K Hold
12,827
– – ﹤0.01% 1858
2025
Q4 		$101K Hold
12,827
– – ﹤0.01% 1694
2025
Q3 		$104K Sell
12,827
-1,378
-10% -$9.15K ﹤0.01% 1661
2025
Q2 		$66.3K Hold
14,205
– – ﹤0.01% 2013
2025
Q1 		$78K Hold
14,205
– – ﹤0.01% 1863
2024
Q4 		$48.2K Hold
14,205
– – ﹤0.01% 2206
2024
Q3 		$40.5K Buy
14,205
+4,275
+43% +$11K ﹤0.01% 2314
2024
Q2 		$22.3K Hold
9,930
– – ﹤0.01% 2562
2024
Q1 		$21.9K Hold
9,930
– – ﹤0.01% 2531
2023
Q4 		$23.3K Hold
9,930
– – ﹤0.01% 2513
2023
Q3 		$18.5K Hold
9,930
– – ﹤0.01% 2573
2023
Q2 		$26K Hold
9,930
– – ﹤0.01% 2421
2023
Q1 		$16.2K Hold
9,930
– – ﹤0.01% 2537
2022
Q4 		$12.3K Hold
9,930
– – ﹤0.01% 2753
2022
Q3 		$15K Hold
9,930
– – ﹤0.01% 2659
2022
Q2 		$15K Buy
+9,930
New +$21K ﹤0.01% 2700
2021
Q2 		– Sell
-3,103
Closed -$14K – 3246
2021
Q1 		$14K Hold
3,103
– – ﹤0.01% 2724
2020
Q4 		$15K Hold
3,103
– – ﹤0.01% 2628
2020
Q3 		$18K Hold
3,103
– – ﹤0.01% 2442
2020
Q2 		$8K Buy
3,103
+1,415
+84% +$4.93K ﹤0.01% 2844
2020
Q1 		$3K Hold
1,688
– – ﹤0.01% 2932
2019
Q4 		$12K Hold
1,688
– – ﹤0.01% 2669
2019
Q3 		$17K Hold
1,688
– – ﹤0.01% 2487
2019
Q2 		$19K Hold
1,688
– – ﹤0.01% 2484
2019
Q1 		$17K Buy
1,688
+1,143
+210% +$14.6K ﹤0.01% 2473
2018
Q4 		$9K Hold
545
– – ﹤0.01% 2717
2018
Q3 		$10K Buy
+545
New +$11.8K ﹤0.01% 2837

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameritas Investment Partners's XERS Position: Q1 2026 in Review

Ameritas Investment Partners held its Xeris Biopharma Holdings (XERS) position steady in Q1 2026 at 12,827 shares worth $74.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1858.

Ameritas Investment Partners first reported a position in XERS in Q3 2018 and has held it in 27 quarters since. The position peaked at $104K in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Ameritas Investment Partners held 12,827 shares of Xeris Biopharma Holdings worth $74.4K as of Q1 2026.
  • Ameritas Investment Partners left its Xeris Biopharma Holdings share count unchanged in Q1 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1858 holding.
  • Ameritas Investment Partners first reported a position in Xeris Biopharma Holdings in Q3 2018 and has held it in 27 quarters since.
  • Ameritas Investment Partners's Xeris Biopharma Holdings position peaked at $104K in Q3 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.